Hutch News

Hutch News

Stories tagged 'Cameron Turtle'

Promising results in trial of engineered T cells in high-risk leukemia

High response rates to experimental immunotherapy in patients with treatment-resistant chronic lymphocytic leukemia

July 17, 2017 | By Susan Keown / Fred Hutch News Service

Most patients with recurrent chronic lymphocytic leukemia who were enrolled in a small, early- phase trial saw their advanced tumors shrink or even disappear after an infusion of genetically engineered immune cells. Dr. Cameron Turtle, one of the study’s leaders, presented the results on Saturday at the 2016 annual meeting of the American Society of Hematology in San Diego.

View story >


‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies

Dec. 16, 2016 | By Susan Keown / Fred Hutch News Service

Lymphoma survivor Stephanie Florence said she wouldn't be alive if not for the science done at Fred Hutchinson Cancer Research Center. This week, she cut the ribbon at the grand opening of the Bezos Family Immunotherapy Clinic, which will make it possible for twice as many patients like Florence to receive treatment.

View story >


Hutch News

Nov. 21, 2016

Stories include: world-renowned oncologist recruited to Fred Hutch, lymphoma patients in remission after experimental immunotherapy and more.

View story >


Patients with advanced lymphoma in remission after T-cell therapy

New study: 7 of 11 trial participants who got two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission

Sept. 7, 2016 | By Susan Keown / Fred Hutch News Service

Seven of 11 trial participants who got a two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission, a new study found.

View story >


Hutch News

Stories include: pregnancy and cancer diagnosis, new strides in metastatic breast cancer research, incredible remission rates after immunotherapy and more

June 15, 2016

Recent stories from Fred Hutch News Service include pregnancy and cancer diagnosis, new strides in metastatic breast cancer research, incredible remission rates after immunotherapy and more.

View story >


Big takeaways from ASCO

Immunotherapy, precision medicine and patient-powered research among the highlights of the world’s largest cancer conference

June 9, 2016 | By Diane Mapes / Fred Hutch News Service

The world's largest cancer conference just ended. Fred Hutch experts and others weigh in on some of the big takeaways.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.